Your browser doesn't support javascript.
loading
Combination leflunomide and methotrexate impedes the recovery of liver fibrosis, partly through inhibition of myeloid cell admittance.
Lin, Mengxin; Guo, Ruyi; Su, Zhijun; Ke, Shaopeng; Zeng, Dawu.
Afiliação
  • Lin M; Department of Infectious Disease, The First Hospital of Quanzhou City, Quanzhou, Fujian 362000, P.R. China.
  • Guo R; Department of Infectious Disease, The First Hospital of Quanzhou City, Quanzhou, Fujian 362000, P.R. China.
  • Su Z; Department of Infectious Disease, The First Hospital of Quanzhou City, Quanzhou, Fujian 362000, P.R. China.
  • Ke S; Department of Infectious Disease, The First Hospital of Quanzhou City, Quanzhou, Fujian 362000, P.R. China.
  • Zeng D; Department of Infectious Disease, The First Hospital of Quanzhou City, Quanzhou, Fujian 362000, P.R. China.
Mol Med Rep ; 19(3): 1622-1628, 2019 Mar.
Article em En | MEDLINE | ID: mdl-30628675

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Metotrexato / Fator A de Crescimento do Endotélio Vascular / Leflunomida / Cirrose Hepática Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans / Male Idioma: En Revista: Mol Med Rep Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Metotrexato / Fator A de Crescimento do Endotélio Vascular / Leflunomida / Cirrose Hepática Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans / Male Idioma: En Revista: Mol Med Rep Ano de publicação: 2019 Tipo de documento: Article